FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890977830> ?p ?o ?g. }

• W2890977830 endingPage "2096" @default.
• W2890977830 startingPage "2088" @default.
• W2890977830 abstract "In the POLLUX study, daratumumab plus lenalidomide/dexamethasone significantly reduced risk of progression/death versus lenalidomide/dexamethasone alone in relapsed/refractory multiple myeloma. We provide one additional year of follow up and include the effect on minimal residual disease and in clinically relevant subgroups. After 25.4 months of follow up, daratumumab plus lenalidomide/dexamethasone prolonged progression-free survival versus lenalidomide/dexamethasone alone (median not reached vs. 17.5 months; hazard ratio, 0.41; 95% confidence interval, 0.31-0.53; P" @default.
• W2890977830 created "2018-09-27" @default.
• W2890977830 creator A5003294000 @default.
• W2890977830 creator A5004321069 @default.
• W2890977830 creator A5004781025 @default.
• W2890977830 creator A5006108161 @default.
• W2890977830 creator A5009395461 @default.
• W2890977830 creator A5011533368 @default.
• W2890977830 creator A5011827756 @default.
• W2890977830 creator A5012877479 @default.
• W2890977830 creator A5015733850 @default.
• W2890977830 creator A5015911442 @default.
• W2890977830 creator A5018685925 @default.
• W2890977830 creator A5020989412 @default.
• W2890977830 creator A5022259689 @default.
• W2890977830 creator A5035520823 @default.
• W2890977830 creator A5038580329 @default.
• W2890977830 creator A5042319853 @default.
• W2890977830 creator A5042534139 @default.
• W2890977830 creator A5042764660 @default.
• W2890977830 creator A5054952877 @default.
• W2890977830 creator A5065238694 @default.
• W2890977830 creator A5065915270 @default.
• W2890977830 creator A5066247828 @default.
• W2890977830 creator A5070014603 @default.
• W2890977830 creator A5073964632 @default.
• W2890977830 creator A5075286184 @default.
• W2890977830 creator A5077897003 @default.
• W2890977830 creator A5078852881 @default.
• W2890977830 creator A5081769123 @default.
• W2890977830 creator A5083639923 @default.
• W2890977830 creator A5084124427 @default.
• W2890977830 creator A5086077649 @default.
• W2890977830 creator A5088402798 @default.
• W2890977830 creator A5088824120 @default.
• W2890977830 date "2018-09-20" @default.
• W2890977830 modified "2023-10-17" @default.
• W2890977830 title "Daratumumab plus lenalidomide and dexamethasone <i>versus</i> lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX" @default.
• W2890977830 cites W1585625390 @default.
• W2890977830 cites W1985864219 @default.
• W2890977830 cites W1990733654 @default.
• W2890977830 cites W2003734726 @default.
• W2890977830 cites W2020298011 @default.
• W2890977830 cites W2044436186 @default.
• W2890977830 cites W2066800926 @default.
• W2890977830 cites W2100718970 @default.
• W2890977830 cites W2141133799 @default.
• W2890977830 cites W2141502099 @default.
• W2890977830 cites W2162771614 @default.
• W2890977830 cites W2201190784 @default.
• W2890977830 cites W2227353206 @default.
• W2890977830 cites W2325601336 @default.
• W2890977830 cites W2330963865 @default.
• W2890977830 cites W2343386476 @default.
• W2890977830 cites W2400276917 @default.
• W2890977830 cites W2443548094 @default.
• W2890977830 cites W2486629951 @default.
• W2890977830 cites W2512106959 @default.
• W2890977830 cites W2528329272 @default.
• W2890977830 cites W2767242921 @default.
• W2890977830 doi "https://doi.org/10.3324/haematol.2018.194282" @default.
• W2890977830 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6269302" @default.
• W2890977830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30237262" @default.
• W2890977830 hasPublicationYear "2018" @default.
• W2890977830 type Work @default.
• W2890977830 sameAs 2890977830 @default.
• W2890977830 citedByCount "174" @default.
• W2890977830 countsByYear W28909778302018 @default.
• W2890977830 countsByYear W28909778302019 @default.
• W2890977830 countsByYear W28909778302020 @default.
• W2890977830 countsByYear W28909778302021 @default.
• W2890977830 countsByYear W28909778302022 @default.
• W2890977830 countsByYear W28909778302023 @default.
• W2890977830 crossrefType "journal-article" @default.
• W2890977830 hasAuthorship W2890977830A5003294000 @default.
• W2890977830 hasAuthorship W2890977830A5004321069 @default.
• W2890977830 hasAuthorship W2890977830A5004781025 @default.
• W2890977830 hasAuthorship W2890977830A5006108161 @default.
• W2890977830 hasAuthorship W2890977830A5009395461 @default.
• W2890977830 hasAuthorship W2890977830A5011533368 @default.
• W2890977830 hasAuthorship W2890977830A5011827756 @default.
• W2890977830 hasAuthorship W2890977830A5012877479 @default.
• W2890977830 hasAuthorship W2890977830A5015733850 @default.
• W2890977830 hasAuthorship W2890977830A5015911442 @default.
• W2890977830 hasAuthorship W2890977830A5018685925 @default.
• W2890977830 hasAuthorship W2890977830A5020989412 @default.
• W2890977830 hasAuthorship W2890977830A5022259689 @default.
• W2890977830 hasAuthorship W2890977830A5035520823 @default.
• W2890977830 hasAuthorship W2890977830A5038580329 @default.
• W2890977830 hasAuthorship W2890977830A5042319853 @default.
• W2890977830 hasAuthorship W2890977830A5042534139 @default.
• W2890977830 hasAuthorship W2890977830A5042764660 @default.
• W2890977830 hasAuthorship W2890977830A5054952877 @default.
• W2890977830 hasAuthorship W2890977830A5065238694 @default.
• W2890977830 hasAuthorship W2890977830A5065915270 @default.
• W2890977830 hasAuthorship W2890977830A5066247828 @default.
• W2890977830 hasAuthorship W2890977830A5070014603 @default.
• W2890977830 hasAuthorship W2890977830A5073964632 @default.

• next